» Articles » PMID: 19607757

Neonatal Infection with Neurotropic Influenza A Virus Induces the Kynurenine Pathway in Early Life and Disrupts Sensorimotor Gating in Adult Tap1-/- Mice

Overview
Specialty Psychiatry
Date 2009 Jul 18
PMID 19607757
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological studies suggest that early life infections may contribute to the development of neuropsychiatric disorders later in life. Experimental studies employing infections during neonatal life support this notion by reporting persistent changes in the behaviour of adult animals, including deficits in sensorimotor gating. We have previously described an induction of the kynurenine pathway in neonatal wild-type (WT) mice following a systemic infection with neurotropic influenza A/WSN/33 virus. Here, we use the same model of infection in both WT and Tap1-/- mice (expressing reduced levels of MHC class I) and study long-term effects of the infection on sensorimotor gating, as determined by measuring prepulse inhibition (PPI). Moreover, transcription of genes encoding enzymes in the kynurenine pathway and levels of kynurenic acid (KYNA), in the brain of Tap1-/- mice were investigated. In mice infected on postnatal day (P)3 or P4, the levels of several transcripts in the kynurenine pathway were altered at P7, P13 and P24. Transcripts encoding indoleamine-pyrrole 2,3-dioxygenase (IDO), degrading tryptophan in the first step of the kynurenine pathway were consistently up-regulated at all time-points investigated. The changes in transcript levels were accompanied by a transient elevation of KYNA in the brain of infected mice at P13. At age 5-6 months, neonatally infected Tap1-/-, but not WT, mice exhibited a reduction in PPI. The present data show that a neonatal infection targeting the brain can induce the kynurenine pathway and that such an infection can disrupt sensorimotor gating in adulthood in genetically vulnerable mice.

Citing Articles

Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.

Pocivavsek A, Schwarcz R, Erhardt S Pharmacol Rev. 2024; 76(6):978-1008.

PMID: 39304346 PMC: 11549936. DOI: 10.1124/pharmrev.124.000239.


The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling.

Yang H, Dong Y, Bian Y, Xu N, Wu Y, Yang F Nat Commun. 2022; 13(1):6288.

PMID: 36271046 PMC: 9586965. DOI: 10.1038/s41467-022-33909-2.


Potential Molecular Mechanisms and Remdesivir Treatment for Acute Respiratory Syndrome Corona Virus 2 Infection/COVID 19 Through RNA Sequencing and Bioinformatics Analysis.

Prashanth G, Vastrad B, Vastrad C, Kotrashetti S Bioinform Biol Insights. 2022; 15:11779322211067365.

PMID: 34992355 PMC: 8725226. DOI: 10.1177/11779322211067365.


Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice.

Imbeault S, Gubert Olive M, Jungholm O, Erhardt S, Wigstrom H, Engberg G Int J Tryptophan Res. 2021; 14:11786469211041368.

PMID: 34483669 PMC: 8411644. DOI: 10.1177/11786469211041368.


Nutritional Support of Neurodevelopment and Cognitive Function in Infants and Young Children-An Update and Novel Insights.

Cohen Kadosh K, Muhardi L, Parikh P, Basso M, Jan Mohamed H, Prawitasari T Nutrients. 2021; 13(1).

PMID: 33435231 PMC: 7828103. DOI: 10.3390/nu13010199.


References
1.
Takikawa O, Kuroiwa T, Yamazaki F, Kido R . Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem. 1988; 263(4):2041-8. View

2.
Tohmi M, Tsuda N, Watanabe Y, Kakita A, Nawa H . Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neurosci Res. 2004; 50(1):67-75. DOI: 10.1016/j.neures.2004.05.010. View

3.
Costa E Silva J . Autism, a brain developmental disorder: some new pathopysiologic and genetics findings. Metabolism. 2008; 57 Suppl 2:S40-3. DOI: 10.1016/j.metabol.2008.07.005. View

4.
King N, Thomas S . Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol. 2007; 39(12):2167-72. DOI: 10.1016/j.biocel.2007.01.004. View

5.
Guidetti P, Amori L, Sapko M, Okuno E, Schwarcz R . Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem. 2007; 102(1):103-11. DOI: 10.1111/j.1471-4159.2007.04556.x. View